179 related articles for article (PubMed ID: 21406435)
1. Early versus late oseltamivir treatment in severely ill patients with 2009 pandemic influenza A (H1N1): speed is life.
Kumar A
J Antimicrob Chemother; 2011 May; 66(5):959-63. PubMed ID: 21406435
[TBL] [Abstract][Full Text] [Related]
2. Impact of early oseltamivir treatment on outcome in critically ill patients with 2009 pandemic influenza A.
Rodríguez A; Díaz E; Martín-Loeches I; Sandiumenge A; Canadell L; Díaz JJ; Figueira JC; Marques A; Alvarez-Lerma F; Vallés J; Baladín B; García-López F; Suberviola B; Zaragoza R; Trefler S; Bonastre J; Blanquer J; Rello J;
J Antimicrob Chemother; 2011 May; 66(5):1140-9. PubMed ID: 21385717
[TBL] [Abstract][Full Text] [Related]
3. Failure of combination oral oseltamivir and inhaled zanamivir antiviral treatment in ventilator- and ECMO-treated critically ill patients with pandemic influenza A (H1N1)v.
Petersen E; Keld DB; Ellermann-Eriksen S; Gubbels S; Ilkjær S; Jensen-Fangel S; Lindskov C
Scand J Infect Dis; 2011 Jul; 43(6-7):495-503. PubMed ID: 21309638
[TBL] [Abstract][Full Text] [Related]
4. 2009 Influenza A H1N1 infections: delays in starting treatment with oseltamivir were associated with a more severe disease.
Launes C; García-García JJ; Jordán I; Martínez-Planas A; Selva L; Muñoz-Almagro C
Pediatr Infect Dis J; 2011 Jul; 30(7):622-5. PubMed ID: 21200359
[TBL] [Abstract][Full Text] [Related]
5. Delayed oseltamivir treatment is associated with longer viral shedding of pandemic (H1N1) 2009 virus.
Leung YH; Lim WL; Wong MH; Chuang SK
Epidemiol Infect; 2012 May; 140(5):814-7. PubMed ID: 21801465
[TBL] [Abstract][Full Text] [Related]
6. Pandemic (H1N1) 2009 virus infection: persistent viral shedding after Oseltamivir treatment.
Kanchana S; Kanchana S; Chuntrakul C; Malathum K; Prachayangprecha S; Poovorawan Y
J Infect; 2011 Oct; 63(4):295-9. PubMed ID: 21840339
[TBL] [Abstract][Full Text] [Related]
7. Duration of viral shedding in patients admitted to hospital with pandemic influenza A/H1N1 2009 infection.
Na S; Chong YP; Kim MN; Kim WY; Kim W; Hong SB; Lim CM; Koh Y; Kwon JW; Hong SJ; Lee SO; Choi SH; Kim YS; Woo JH; Kim SH
J Med Virol; 2011 Jan; 83(1):5-9. PubMed ID: 21108333
[TBL] [Abstract][Full Text] [Related]
8. Very low pandemic influenza A (H1N1) 2009 mortality associated with early neuraminidase inhibitor treatment in Japan: analysis of 1000 hospitalized children.
Sugaya N; Shinjoh M; Mitamura K; Takahashi T
J Infect; 2011 Oct; 63(4):288-94. PubMed ID: 21722665
[TBL] [Abstract][Full Text] [Related]
9. Influenza A/H1N1 2009 pneumonia in kidney transplant recipients: characteristics and outcomes following high-dose oseltamivir exposure.
Watcharananan SP; Suwatanapongched T; Wacharawanichkul P; Chantratitaya W; Mavichak V; Mossad SB
Transpl Infect Dis; 2010 Apr; 12(2):127-31. PubMed ID: 20102550
[TBL] [Abstract][Full Text] [Related]
10. Oseltamivir-induced resistant pandemic A/H1N1 influenza virus in a child with cystic fibrosis and Pseudomonas aeruginosa infection.
Esposito S; Molteni CG; Colombo C; Daleno C; Daccò V; Lackenby A; Principi N
J Clin Virol; 2010 May; 48(1):62-5. PubMed ID: 20335065
[TBL] [Abstract][Full Text] [Related]
11. Possible neuropsychiatric reaction to high-dose oseltamivir during acute 2009 H1N1 influenza A infection.
Nakamura K; Schwartz BS; Lindegårdh N; Keh C; Guglielmo BJ
Clin Infect Dis; 2010 Apr; 50(7):e47-9. PubMed ID: 20192728
[TBL] [Abstract][Full Text] [Related]
12. Oseltamivir-resistant 2009 pandemic influenza A (H1N1) virus infection in two summer campers receiving prophylaxis--North Carolina, 2009.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2009 Sep; 58(35):969-72. PubMed ID: 19745803
[TBL] [Abstract][Full Text] [Related]
13. Effects of early oseltamivir therapy on viral shedding in 2009 pandemic influenza A (H1N1) virus infection.
Ling LM; Chow AL; Lye DC; Tan AS; Krishnan P; Cui L; Win NN; Chan M; Lim PL; Lee CC; Leo YS
Clin Infect Dis; 2010 Apr; 50(7):963-9. PubMed ID: 20180701
[TBL] [Abstract][Full Text] [Related]
14. Antiviral drugs in influenza: an adjunct to vaccination in some situations.
Prescrire Int; 2006 Feb; 15(81):21-30. PubMed ID: 16548114
[TBL] [Abstract][Full Text] [Related]
15. The use of antiviral agents for the management of severe influenza.
Smith JR; Ariano RE; Toovey S
Crit Care Med; 2010 Apr; 38(4 Suppl):e43-51. PubMed ID: 19935416
[TBL] [Abstract][Full Text] [Related]
16. Fatal cases of pandemic (H1N1) 2009 influenza despite their early antiviral treatment in Japan.
Nukiwa N; Kamigaki T; Oshitani H
Clin Infect Dis; 2010 Oct; 51(8):993-4. PubMed ID: 20858082
[No Abstract] [Full Text] [Related]
17. Influenza in the immediate post-pandemic era: a comparison with seasonal and pandemic influenza in hospitalized patients.
Rahamat-Langendoen JC; Tutuhatunewa ED; Schölvinck EH; Hak E; Koopmans M; Niesters HG; Riezebos-Brilman A
J Clin Virol; 2012 Jun; 54(2):135-40. PubMed ID: 22398034
[TBL] [Abstract][Full Text] [Related]
18. Treatment options for 2009 H1N1 influenza: evaluation of the published evidence.
Falagas ME; Vouloumanou EK; Baskouta E; Rafailidis PI; Polyzos K; Rello J
Int J Antimicrob Agents; 2010 May; 35(5):421-30. PubMed ID: 20185273
[TBL] [Abstract][Full Text] [Related]
19. Characteristics of pregnant Japanese women who required hospitalization for treatment of pandemic (H1N1) 2009--low mortality rate may be due to early antiviral use.
Nakai A; Minakami H; Unno N; Saito S; Morikawa M; Yoshimura Y; Terao T
J Infect; 2011 Mar; 62(3):232-3. PubMed ID: 21237199
[No Abstract] [Full Text] [Related]
20. Treatment with neuraminidase inhibitors for critically ill patients with influenza A (H1N1)pdm09.
Louie JK; Yang S; Acosta M; Yen C; Samuel MC; Schechter R; Guevara H; Uyeki TM
Clin Infect Dis; 2012 Nov; 55(9):1198-204. PubMed ID: 22843781
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]